Rob checks in with this blue legend on today’s segment of the Daily Stock Watch.

The Legacy bans have Adrian considering what the new meta might do to MTGO prices. A couple cards with low buy-ins look particularly well-positioned in the new environment.

Jace and Bloodbraid continue to be the main story of the Modern metagame. Adrian looks at the cards’ impact two weeks out and advises where to park investment money.

David reviews some cards that show promise with the recent Modern B&R Announcement.

This week, David breaks down a few format staples for five major formats, compares their buylist prices from five top stores, and draws a number of conclusions from the data. If you like getting deep into the numbers, this article is for you.

The full Rivals of Ixalan spoiler is out, and David is here to cover the interesting cards for eternal play from both strategic and financial perspectives.

Rob starts the week with a look at Dictate of Erebos.

Kyle provides a nice analysis of the factors to consider when investing in Masters sets – most recently, Iconic Master.

Rob thinks it’s time to burn some willows with this card!

GP Vegas is bound to shake up both Legacy and Modern. Brian presents his picks for the cards most likely to respond with a price increase.

On the surface MTG finance looks healthy, but there are some areas of weakness. This begs the question: do we stick with what’s working or shift to the underperformers?

The Legacy metagame was thrown on its head after the banning of Sensei’s Divining Top, and many cards have benefited from the change…